Global Proteomics Market is estimated to be valued at USD 123.1 Billion by 2035, with an exponential growth of 12.55% in the ...

The options have an exercise price of $7.95 per share, which is equal to the closing price of BioCryst common stock on the grant date. The options and RSUs vest in four equal annual installments ...